
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need. Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0879 | 12.3437719421 | 0.7121 | 0.86 | 0.66 | 172711 | 0.68819414 | CS |
4 | -0.1409 | -14.9750239133 | 0.9409 | 1.01 | 0.66 | 163517 | 0.7829938 | CS |
12 | -0.1401 | -14.9026699287 | 0.9401 | 1.59 | 0.66 | 343337 | 1.14207459 | CS |
26 | -2.03 | -71.7314487633 | 2.83 | 2.83 | 0.66 | 363827 | 1.311322 | CS |
52 | -3.77 | -82.4945295405 | 4.57 | 6.8 | 0.66 | 242625 | 2.19584669 | CS |
156 | -7.95 | -90.8571428571 | 8.75 | 8.99 | 0.66 | 169567 | 3.63818142 | CS |
260 | -24.96 | -96.8944099379 | 25.76 | 95.375 | 0.66 | 207888 | 16.09447511 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions